Can International Patent Law Help Mitigate Cancer Inequity in LMICs?

AMA Journal of Ethics, Volume 22, Number 2: E102-111

8 Pages Posted: 19 Feb 2021

See all articles by Srividhya Ragavan

Srividhya Ragavan

Texas A&M University School of Law

Amaka Vanni

affiliation not provided to SSRN

Date Written: May 24, 2020

Abstract

Although low- and middle-income countries (LMICs) bear 75% of the cancer burden globally, their available resources to treat cancer constitute less than 5% of global health resources. This inequity makes it imperative to take appropriate measures to treat and prevent cancer in LMICs, which should include consideration of trade and patent policies. This article highlights some impediments to effective use of existing policies to promote access to treatment and prevention measures in LMICs and offers recommendations about next steps.

Keywords: Pharmaceutical patent Law, access to medicines, LMICs

Suggested Citation

Ragavan, Srividhya and Vanni, Amaka, Can International Patent Law Help Mitigate Cancer Inequity in LMICs? (May 24, 2020). AMA Journal of Ethics, Volume 22, Number 2: E102-111, Available at SSRN: https://ssrn.com/abstract=3609147 or http://dx.doi.org/10.2139/ssrn.3609147

Srividhya Ragavan

Texas A&M University School of Law ( email )

1515 Commerce Street
Fort Worth, TX 76102
United States

Amaka Vanni (Contact Author)

affiliation not provided to SSRN

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
9
Abstract Views
108
PlumX Metrics